Fundz

Cassidy Bio raises $8M in seed funding to advance its AI-driven gene editing therapies, aiming to enhance safety and scalability.

PRIVATENov 20, 2025

Amount Raised

$8 Million

Round Type

Seed

Tel AvivBiotechnologyArtificial Intelligence

Investors

Lool VenturesAhren Innovation Capital

Description

Cassidy Bio has launched with a vision to develop safer gene editing therapies powered by AI. The company secured $8 million in a seed financing round to enhance its unique genomic foundation model. This funding will help accelerate the development of precision gene therapies. Cassidy aims to transform the landscape of genome editing with its innovative approach.

Quick answer

Cassidy Bio raised $8 Million in a Seed round, dated November 20, 2025. Investors: Lool Ventures and Ahren Innovation Capital. Cassidy Bio is based in Tel Aviv, Tel Aviv District, Israel.

How much did Cassidy Bio raise?
Cassidy Bio raised $8 Million in a Seed round on November 20, 2025.
Who invested in Cassidy Bio?
Lool Ventures and Ahren Innovation Capital are named as investors in this round.
What does Cassidy Bio do?
Cassidy Bio is an AI-first biotechnology company building the first programmable platform for gene editing.
Where is Cassidy Bio based and how big is it?
Cassidy Bio is based in Tel Aviv, Tel Aviv District, Israel. Fundz records about 23 employees.
Who are the decision-makers at Cassidy Bio?
Fundz holds 1 contact at Cassidy Bio, including the CTO & Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Artificial Intelligence around the same time

Companies in the same sectors as Cassidy Bio that raised within 45 days of this round, from Fundz verified event records.

  • DP Technology raised $114M (Series C) on December 24, 2025.
  • Qureator raised $6.7M on December 23, 2025.
  • Galatek raised $30M (Series A) on December 19, 2025.
  • Edison Scientific raised $70M (Seed) on December 18, 2025.
  • Novyte Materials raised $459K (Pre-Seed) on December 18, 2025.
  • Arcreal raised $5.4M (Pre-Series A) on December 17, 2025.

Who to call at Cassidy Bio, and when

A new round usually means Cassidy Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cassidy Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cassidy Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cassidy Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cassidy Bio

Location

Tel Aviv, Tel Aviv District, Israel

About

Cassidy Bio is an AI-first biotechnology company building the first programmable platform for gene editing. Cassidy Bio replaces the narrow, trial-and-error design process with large-scale prediction, simulation, and in silico validation, powered by genomic foundation models trained on proprietary biological data. The platform scales to connect across multiple components guides, editing systems, delivery systems and variant backgrounds ranking designs by safety and efficacy. Cassidy Bio’s vision is to enable not just one-off miracles, but a new generation of reliable gene editing therapies at scale.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cassidy Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsYaniv S., CTO & Co-FounderSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cassidy Bio's next move

See what Strategic adds

Cassidy Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.